Medicine and Dentistry
Adenoviridae
21%
Analysis
21%
Androgen Receptor
13%
Biopsy
17%
Bladder Cancer
41%
Bleeding
13%
Cancer Cell
25%
Cells
30%
Clear Cell Renal Cell Carcinoma
45%
Combination Therapy
14%
Complication
18%
Computer Assisted Tomography
9%
Coxsackie Virus and Adenovirus Receptor
11%
Development
11%
Diagnosis
11%
Diseases
11%
Enhancer Region
12%
Follow up
19%
Gene
23%
Gene Therapy
15%
Hazard Ratio
12%
Histone Deacetylase Inhibitor
10%
In Vitro
11%
Inferior Vena Cava
11%
Inpatient
10%
Kidney
23%
Kidney Tumour
20%
Lesion
19%
Malignant Neoplasm
23%
Metastatic Carcinoma
14%
Mortality
17%
N (4 Methoxyphenylacetyl)dehydroalanine
9%
Neoplasm
71%
Overall Survival
9%
Partial Nephrectomy
23%
Patient
100%
Predictor
10%
Promoter Region
13%
Prostate Cancer
35%
Prostate Specific Membrane Antigen
13%
Radical Nephrectomy
16%
Recurrent Disease
13%
Sodium Valproate
22%
Stromal Tumor
12%
Surgery
12%
Survival
17%
Therapeutic Procedure
51%
Tissues
24%
Transitional Cell Carcinoma
10%
Tumor Thrombus
13%
Biochemistry, Genetics and Molecular Biology
Adenoviridae
24%
Androgen Receptor
38%
Angiogenesis
5%
Cancer Cell
29%
Chicken
8%
Development
12%
Diphtheria Toxin
5%
DNA
8%
Electric Potential
5%
Enhancer Region
12%
Fibrinogen Blood Level
6%
Gene Therapy
9%
Growth
9%
Luciferase
12%
MicroRNA
6%
NAD(P)H Oxidase
5%
Nested Gene
32%
P21
9%
Peptide
9%
Polyadenylation
6%
Progesterone Receptor
12%
Promoter Region
18%
Prostate-Specific Antigen
5%
Radiation
8%
Response Element
6%
Sample
7%
Stem Cell
8%
Time
6%
Transcription
5%
Transfer Gene
6%
Virus
10%
Virus Replication
6%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
16%
Androgen
5%
Androgen Receptor
15%
Bladder Cancer
25%
Histone Deacetylase Inhibitor
8%
Hormone
6%
Mouse
6%
N (4 Methoxyphenylacetyl)dehydroalanine
5%
Neoplasm
7%
Oncolytic Adenovirus
10%
Prostate Cancer
34%
Prostate Specific Antigen
12%
Prostate Stem Cell Antigen
5%
Radiation
7%
Sodium Valproate
22%
Toxicity
5%
Virus
5%
Western Blot
7%
